Who owns the GENERATE:BIOMEDICINES trademark?

The GENERATE:BIOMEDICINES trademark is owned by Generate Biomedicines, Inc..

What class is the GENERATE:BIOMEDICINES trademark registered in?

The GENERATE:BIOMEDICINES trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for GENERATE:BIOMEDICINES?

The USPTO serial number for GENERATE:BIOMEDICINES is 98308316.

What is the registration number for GENERATE:BIOMEDICINES?

GENERATE:BIOMEDICINES is registered under USPTO registration number 0.

GEN

USPTO Trademark Record

PENDING

GENERATE:BIOMEDICINES

SN 98308316·Reg 0·Filed Dec 11, 2023

Owner Generate Biomedicines, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GENERATE:BIOMEDICINES (Serial No. 98308316), Registration No. 0, is a pending US trademark filed on Dec 11, 2023 by Generate Biomedicines, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

GENERATE:BIOMEDICINES (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Dec 11, 2023

SERIAL

98308316

REG#

Owner

Applicant

Generate Biomedicines, Inc.

Entity

Corporation

State

Address

101 South Street, Suite 900, Somerville, MA, 02143

Country

Attorney

NameJennifer M. Mikulina

Law firm

Jennifer M. Mikulina McDermott Will & Schulte LLP

Docket

119073-0076

Address

444 West Lake Street, Suite 4000, Chicago, IL 60606-0029, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateDec 11, 2023

Serial Number98308316

Registration No.0

Status DateJul 08, 2026

Mark TypeStandard characters

Attorney Docket119073-0076

Status DescriptionLive and pending, report completed suspension check

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Suspension deadline Oct 08, 2026

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 21, 2021

First use in commerce: Dec 21, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jul 08, 2026

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jan 08, 2026

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 03, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Sep 03, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 03, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 03, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 03, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jul 07, 2025

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Feb 01, 2025

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Jul 05, 2024

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Jul 05, 2024

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 05, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 03, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 03, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 03, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 08, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 08, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 08, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 03, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 12, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 11, 2023

NEW APPLICATION ENTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

GEN

GENERATE:BIOMEDICINES

98113071

Generate Biomedicines, Inc.

PENDING

GENERATE:BIOMEDICINES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Generate Biomedicines, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jennifer M. Mikulina

Industries

USPTO Deadlines

Compare

Resources

Company